BridgeMD
New treatment option for Premature Birth
Official title Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality
ClinicalTrials.gov ID: NCT06224764
What this study is testing
- What it's testing
- The aim of this study is to evaluate the impact of discharge from hospital with a weight of less than 2 kilos. To do this, the investigator will look at the short-term and long-term outcome of newborns weighing less than 2 kilos who were discharged from the neonatology department at the NOVO hospital between 2012 and 2024.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 11
You may be able to join if
- Premature newborn baby (born at less than 37 days' gestation)
- Newborn baby with IUGR (Intra-Uterine Growth Retardation)
- Newborn baby hospitalised in the neonatology department of the NOVO hospital - Pontoise site
- Patient born between 01/01/2012 and 31/12/2024.
- Newborn who has left the neonatology department or the Kangaroo Unit to return home weighing less than 2 kg.
You likely can't join if
- Newborn transferred to another hospital before discharge.
- Refusal by one of the parents.
- Parent does not speak or understand French.
See the full eligibility criteria
- Premature newborn baby (born at less than 37 days' gestation)
- Newborn baby with IUGR (Intra-Uterine Growth Retardation)
- Newborn baby hospitalised in the neonatology department of the NOVO hospital - Pontoise site
- Patient born between 01/01/2012 and 31/12/2024.
- Newborn who has left the neonatology department or the Kangaroo Unit to return home weighing less than 2 kg.
- Newborn beneficiary of a social security scheme or entitled person.
- Newborn transferred to another hospital before discharge.
- Refusal by one of the parents.
- Parent does not speak or understand French.
The study team makes the final eligibility decision.
Where it's taking place
- Pontoise, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 11 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pontoise, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.